China Pharma (CPHI) vs Citius Oncology (CTOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
China Pharma (CPHI) has outperformed Citius Oncology (CTOR) over the past year, losing 51.8% versus a loss of 54.6%. Citius Oncology is the larger company by market cap ($88.3 million vs $41.3 million), about 2.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPHI | CTOR |
|---|---|---|
| Share price | $0.96 | $0.835 |
| Market cap | $41.30M | $88.31M |
| 1-day change | +12.94% | -2.45% |
| YTD return | -20.66% | -16.50% |
| 1-year return | -51.76% | -54.62% |
| 5-year return | -99.65% | — |
| EPS (TTM) | $-0.42 | $-0.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.19 | $2.25 |
| 52-week low | $0.38 | $0.491 |
| Distance from 52-week high | -95.00% | -62.89% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +379.04% |
| Average volume | 5.81M | 99.72K |
| Shares outstanding | 43.02M | 105.76M |
| Employees | 215 | — |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Citius Oncology is about 2.1 times larger than China Pharma by market value ($88.31M vs $41.30M).
About China Pharma
CPHI stock →China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China.
Healthcare · Drug Manufacturers - Specialty & Generic · 215 employees
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Healthcare · Drug Manufacturers - Specialty & Generic
CPHI vs CTOR FAQ
Which is bigger, China Pharma or Citius Oncology?
Citius Oncology (CTOR) is larger, with a market capitalization of $88.31M compared with $41.30M for China Pharma (CPHI).
Which stock has performed better over the past year, CPHI or CTOR?
CPHI returned -51.76% over the past 12 months, compared with -54.62% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are China Pharma and Citius Oncology in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.